IN2013MU01782A - - Google Patents

Download PDF

Info

Publication number
IN2013MU01782A
IN2013MU01782A IN1782MU2013A IN2013MU01782A IN 2013MU01782 A IN2013MU01782 A IN 2013MU01782A IN 1782MU2013 A IN1782MU2013 A IN 1782MU2013A IN 2013MU01782 A IN2013MU01782 A IN 2013MU01782A
Authority
IN
India
Prior art keywords
rasagiline
enantiomer
disease
salts
pharmaceutical compositions
Prior art date
Application number
Other languages
English (en)
Inventor
Sushrut Krishnaji Kulkarni
Pavak Rajnikanth Mehta
Ritesh Kapoor
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Priority to IN1782MU2013 priority Critical patent/IN2013MU01782A/en
Priority to PCT/IN2014/000336 priority patent/WO2014192022A1/en
Publication of IN2013MU01782A publication Critical patent/IN2013MU01782A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN1782MU2013 2013-05-20 2014-05-20 IN2013MU01782A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN1782MU2013 IN2013MU01782A (ja) 2013-05-20 2014-05-20
PCT/IN2014/000336 WO2014192022A1 (en) 2013-05-20 2014-05-20 Pharmaceutical compositions of rasagiline

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1782MU2013 IN2013MU01782A (ja) 2013-05-20 2014-05-20

Publications (1)

Publication Number Publication Date
IN2013MU01782A true IN2013MU01782A (ja) 2015-06-26

Family

ID=51300794

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1782MU2013 IN2013MU01782A (ja) 2013-05-20 2014-05-20

Country Status (2)

Country Link
IN (1) IN2013MU01782A (ja)
WO (1) WO2014192022A1 (ja)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111240A (en) * 1993-10-18 2001-10-31 Teva Pharma Salts of r(+) - enantiomers of n- propargyl-1-aminoindan and pharmaceutical compositions comprising them
AU2005269416B2 (en) * 2004-07-26 2011-07-28 Teva Pharmaceutical Industries, Ltd. Pharmaceutical dosage forms including rasagiline
EP1892233A1 (de) * 2006-08-18 2008-02-27 Ratiopharm GmbH Neue Salze des Wirkstoffs Rasagilin
CN1911211B (zh) * 2006-08-25 2010-04-14 重庆医药工业研究院有限责任公司 雷沙吉兰口服固体制剂
EP1987816A1 (de) * 2007-04-30 2008-11-05 Ratiopharm GmbH Adsorbate eines Rasagilinsalzes mit einem wasserlöslichen Hilfsstoff
WO2009122301A2 (en) * 2008-03-31 2009-10-08 Actavis Group Ptc Ehf Rasagiline mesylate particles and process for the preparation thereof
WO2010007181A2 (en) * 2008-07-18 2010-01-21 Medichem, S.A. New salt forms of an aminoindan derivative
WO2010111264A2 (en) * 2009-03-24 2010-09-30 Dr. Reddy's Laboratories Ltd. Rasagiline formulations
RS53504B1 (en) * 2009-07-09 2015-02-27 Ratiopharm Gmbh RAZAGILIN SALTS AND THEIR PHARMACEUTICAL PREPARATIONS
AU2010274589A1 (en) * 2009-07-23 2012-02-16 Alkem Laboratories Ltd. Oral pharmaceutical composition of rasagiline and process for preparing thereof
US20120269871A1 (en) * 2009-12-30 2012-10-25 Actavis Group Ptc Ehf Solid state forms of rasagiline salts
AU2011212068B2 (en) * 2010-02-03 2016-08-18 Pharma Two B Ltd. Extended release formulations of rasagiline and uses thereof
WO2011121607A2 (en) * 2010-03-29 2011-10-06 Cadila Healthcare Limited Rasagiline and its pharmaceutically acceptable salts
EP2389927A1 (en) * 2010-05-30 2011-11-30 Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi Pharmaceutical formulations of rasagiline
WO2012153349A2 (en) * 2011-05-04 2012-11-15 Cadila Healthcare Limited Rasagiline and its pharmaceutically acceptable salts
ES2502140T1 (es) * 2013-02-06 2014-10-02 Galenicum Health S.L. Comprimidos de liberación inmediata de rasagilina hemitartrato

Also Published As

Publication number Publication date
WO2014192022A1 (en) 2014-12-04

Similar Documents

Publication Publication Date Title
MX2017005834A (es) Polinucleotidos aad para el tratamiento de la enfermedad de parkinson.
PH12016501307A1 (en) Compounds
EP3235497A4 (en) Uses of cinacalcet hcl in preparing pharmaceutical composition for treatment of cancer
WO2015085318A3 (en) Targeted adaptive vaccines
IL252091A0 (en) 2-amino-5,3-difluoro-6,3-dimethyl-6-phenyl-6,5,4,3-tetrahydropyridines as bace1 inhibitors for the treatment of Alzheimer's disease
MX2017008136A (es) Sal de l-tartrato de pridopidina.
BR112017007063A2 (pt) ?composições e métodos para o tratamento de insônia?
PH12016500814A1 (en) Heteroaryl butanoic acid derivatives
PH12016501686A1 (en) Pharmaceutical compositions of sitagliptin
MX2017012595A (es) Un extracto de indigo naturalis y un proceso para preparar el mismo.
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
BR112016028316A2 (pt) composição farmacêutica oral de isotretinoina, seu processo de preparação e método de tratamento
BR112016022575A2 (pt) Composições e métodos para o tratamento de doenças neurodegenerativas
IN2014CH00840A (ja)
PH12017500923A1 (en) New dosage and use of a a2a antagonist
PL3352742T3 (pl) Kompozycje zawierające triterpenoidy do leczenia choroby alzheimera i choroby parkinsona
IN2013MU01782A (ja)
IL265656A (en) Preparations and methods for the treatment of Alzheimer's disease and Parkinson's disease
IN2014MU00495A (ja)
IN2013MU02576A (ja)
ZA201801945B (en) Compositions and methods for the treatment of parkinson's disease
DK3148588T3 (en) N,n-bis-2-mercaptoethyl isophthalamide for the treatment of parkinson's disease
EP3085691A4 (en) Method for preparing the anhydrous crystalline form of isoniazid-derived hydrazone, thus produced crystalline polymorph of the anhydrous form, use thereof for the treatment of alzheimer's disease, parkinsonism and other neurodegenerative disorders, and pharmaceutical composition
IN2014MU00276A (ja)